These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 9552031)

  • 1. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.
    Al-Sarraf M; LeBlanc M; Giri PG; Fu KK; Cooper J; Vuong T; Forastiere AA; Adams G; Sakr WA; Schuller DE; Ensley JF
    J Clin Oncol; 1998 Apr; 16(4):1310-7. PubMed ID: 9552031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.
    Al-Sarraf M; LeBlanc M; Giri PG; Fu KK; Cooper J; Vuong T; Forastiere AA; Adams G; Sakr WA; Schuller DE; Ensley JF
    J Clin Oncol; 2023 Aug; 41(24):3965-3972. PubMed ID: 37586209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.
    Lv X; Cao X; Xia WX; Liu KY; Qiang MY; Guo L; Qian CN; Cao KJ; Mo HY; Li XM; Li ZH; Han F; He YX; Liu YM; Wu SX; Bai YR; Ke LR; Qiu WZ; Liang H; Liu GY; Miao JJ; Li WZ; Lv SH; Chen X; Zhao C; Xiang YQ; Guo X
    Lancet Oncol; 2021 May; 22(5):716-726. PubMed ID: 33857411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma.
    Chan AT; Teo PM; Leung TW; Leung SF; Lee WY; Yeo W; Choi PH; Johnson PJ
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):569-77. PubMed ID: 7558945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction chemotherapy with paclitaxel and cisplatin, followed by concomitant cisplatin and radiotherapy for the treatment of locally advanced nasopharyngeal carcinoma.
    Mostafa E; Nasar MN; Rabie NA; Ibrahim SA; Barakat HM; Rabie AN
    J Egypt Natl Canc Inst; 2006 Dec; 18(4):348-56. PubMed ID: 18301458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment results of alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil--a phase II study.
    Fuwa N; Shikama N; Hayashi N; Matsuzuka T; Toita T; Yuta A; Oonishi H; Kodaira T; Tachibana H; Nakamura T; Daimon T
    Oral Oncol; 2007 Oct; 43(9):948-55. PubMed ID: 17257880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma of the undifferentiated type.
    Ong YK; Tan EH; Wee J; Goh CB; Fong KW; Lee KS; Chua EJ
    Ann Acad Med Singap; 1999 Jul; 28(4):525-8. PubMed ID: 10561766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer.
    Oh JL; Vokes EE; Kies MS; Mittal BB; Witt ME; Weichselbaum RR; Haraf DJ
    Ann Oncol; 2003 Apr; 14(4):564-9. PubMed ID: 12649102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
    Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
    Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.
    Benasso M; Sanguineti G; D'Amico M; Corvò R; Ricci I; Numico G; Guarneri D; Vitale V; Pallestrini E; Santelli A; Rosso R
    Br J Cancer; 2000 Dec; 83(11):1437-42. PubMed ID: 11076650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized phase II study comparing sequential versus simultaneous chemo-radiotherapy in patients with unresectable locally advanced squamous cell cancer of the head and neck.
    Pinnarò P; Cercato MC; Giannarelli D; Carlini P; Del Vecchio MR; Impiombato FA; Marzetti F; Milella M; Cognetti F
    Ann Oncol; 1994 Jul; 5(6):513-9. PubMed ID: 7918123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy plus conventional radiotherapy or accelerated hyperfractionation in stage III and IV nasopharyngeal carcinoma--a phase II study.
    El-Weshi A; Khafaga Y; Allam A; Mosseri V; Ibrahim E; El-Serafi M; El-Badawi S
    Acta Oncol; 2001; 40(5):574-81. PubMed ID: 11669328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of carcinoma of the uterine cervix with concomitant cisplatin, 5-fluorouracil and split course hyperfractionated radiotherapy.
    Tubiana-Mathieu N; Bonnier P; Delaby F; Murraciole X; Lejeune C; Hadjadj DJ; Juin P; Piana L
    Eur J Obstet Gynecol Reprod Biol; 1998 Mar; 77(1):95-100. PubMed ID: 9550208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study: concurrent chemo-radiotherapy in advanced nasopharyngeal carcinoma.
    Maoleekoonpairoj S; Phromratanapongse P; Puttanuparp S
    J Med Assoc Thai; 1997 Dec; 80(12):778-84. PubMed ID: 9470331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial.
    Cao SM; Yang Q; Guo L; Mai HQ; Mo HY; Cao KJ; Qian CN; Zhao C; Xiang YQ; Zhang XP; Lin ZX; Li WX; Liu Q; Qiu F; Sun R; Chen QY; Huang PY; Luo DH; Hua YJ; Wu YS; Lv X; Wang L; Xia WX; Tang LQ; Ye YF; Chen MY; Guo X; Hong MH
    Eur J Cancer; 2017 Apr; 75():14-23. PubMed ID: 28214653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.
    Teo PM; Chan AT; Lee WY; Leung TW; Johnson PJ
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):261-71. PubMed ID: 10030248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
    Lin HX; Hua YJ; Chen QY; Luo DH; Sun R; Qiu F; Mo HY; Mai HQ; Guo X; Xian LJ; Hong MH; Guo L
    Chin J Cancer; 2013 Sep; 32(9):502-11. PubMed ID: 23816561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent chemoradiotherapy for locally advanced esophageal cancer--a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil.
    Hsu CH; Yeh KH; Lui LT; Lee YC; Bu CF; Wang HP; Lin JT; Cheng AL
    Anticancer Res; 1999; 19(5C):4463-7. PubMed ID: 10650793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival.
    Lin JC; Jan JS; Hsu CY; Liang WM; Jiang RS; Wang WY
    J Clin Oncol; 2003 Feb; 21(4):631-7. PubMed ID: 12586799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.